Boots is to start prescribing medical cannabis, it has announced, in a first for a UK high street pharmacy. The online service is being offered to patients in the UK aged 25 and older who have an eligible condition such as chronic pain, anxiety or insomnia.
The chain is launching its SureLeaf service alongside a collaborative research programme with the University of Nottingham that will examine patient outcomes, prescribing practices and experience in the treatment of chronic pain.
Patients will be invited to start an assessment online. Their suitability will then be reviewed by a clinical team, before they are invited to a video consultation with a consultant, according to Boots.
Boots said any prescription would be “independently reviewed by a multidisciplinary clinical team that includes a second, independent consultant, before treatment begins”.
It said any patient wishing to be prescribed medical cannabis must first have tried conventional treatments without success. The pharmacy said patients would be regularly reviewed.
Boots’ chief healthcare officer, Jamie Kerruish, said: “Millions of people live with ongoing pain and, for some, conventional treatments do not provide adequate symptom relief. This can have a significant impact on everyday life, from working and sleeping well to spending time with family and doing the things they enjoy.”
The launch makes Boots the first high street pharmacy in the UK to offer prescriptions for medical cannabis to eligible patients through an online service.
Patients in the UK aged 25 and older with an eligible condition will be able to begin the process with an online assessment, after which their suitability will be reviewed by a clinical team before a video consultation with a consultant takes place, according to the company.
Boots said the SureLeaf service and the associated research programme with the University of Nottingham will together examine patient outcomes, prescribing practices and experience in the treatment of chronic pain.
Senate Leader Signals Legalization Is Not a Top Priority Presumptive Senate President Pro Tempore Jay Costa (D) told WHTM-TV in…
The Bill and Its Sponsor Rep. Steve Cohen (D-Tenn.) has introduced the Public Health and Research Reforms in Controlled Substances…
Hemp Retailers Liquidate Inventory Ahead of Ban Hemp retailers across Missouri slashed prices, cleared shelves and, in some cases, gave…
Rescheduling Order Challenged in D.C. Circuit MMJ International Holdings, a pharmaceutical cannabinoid developer pursuing FDA-regulated treatments for Huntington's disease and…
Summit Returns to Washington The IgniteIt Capital & Policy Summit returns to the Grand Hyatt Washington on Wednesday, November 18,…
Court Orders Regulated Cultivation Nepal's Supreme Court has ordered the government to make the "necessary arrangements" for the "controlled cultivation…